Home › Abbott GmbH › ARCHITECT
ARCHITECT
Abbott GmbH · Model 7D62-22 · UDI-DI 00380740161682
CHH
Prescription
10
510(k) clearances
105
Adverse events
23
Recalls
82
Facilities
Description
Cholesterol
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-04-02 | DFI Co., Ltd. | The devices were distributed without required FDA premarket clearance or approval. |
| 2022-06-22 | Randox Laboratories Ltd. | Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower t |
| 2021-11-10 | Beckman Coulter Inc. | Cholesterol Reagent may fail with Out of Calibration Range Low (OCR Low) and/or Back to Back (B/B) errors. Low quality control recovery failures may be observed after passing calib |
| 2021-11-01 | Randox Laboratories Ltd. | When calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range |
| 2019-06-07 | Polymer Technology Systems, Inc. | The MEMo chips provided with lot P901 may be mislabeled, the MEMo Chip may display Q901 on the analyzer LCD screen, instead of P901 |
| 2019-06-07 | Polymer Technology Systems, Inc. | The MEMo chips provided with lot P901 may be mislabeled, the MEMo Chip may display Q901 on the analyzer LCD screen, instead of P901 |
| 2019-01-16 | Polymer Technology Systems, Inc. | Some lots of test strips do not fit tightly into the optical block, and may fall out during analysis, which could lead to an incorrect result being di P832 Chemistry (Diagnostic) C |
| 2019-01-16 | Polymer Technology Systems, Inc. | Some lots of test strips do not fit tightly into the optical block, and may fall out during analysis, which could lead to an incorrect result being displayed. |
| 2017-04-03 | Beckman Coulter Inc. | Beckman Coulter has identified the following drugs as potential sources of interference: Metamizole (Dipyrone), Sulfasalazine, and Sulfapyridine and may result in false low results |
| 2016-07-20 | Sterling Diagnostics, Inc. | Sterling Diagnostics, Inc. initiated a recall on 7/20/2016 for multiple diagnostic kits due to a recision of the previously extended expiration dates for the kits. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.